¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06
±³À°ÀÏÀÚ : 2024-04-06
±³À°Àå¼Ò : ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀǽÇ

±³À°ÁÖÁ¦ : ILCA School of Liver Cancer

ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : ¿ÀÀ±Àç ´ë¸®
¿¬¶ôó : 02-373-1005  

À̸ÞÀÏ : klca@hbni.co.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø  

ºñ°í ILCA member 200,000¿ø / Non member 300,000¿ø / Resident, Fellow, Trainee, Researcher 70,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 08:40~08:55 Exploring Tumor Microenvironment and Immunology in HCC Pil Soo Sung(The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 08:55~09:10 The Oncogenomic Landscape in HCC Sun Young Yim(Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:10~09:25 Pathological and Molecular Features of HCC and CCC Haeryoung Kim (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:25~09:40 Molecular Features and Classification of ICC and Combined HCC-CCC Hyun Goo Woo (Ajou Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:40~10:00 Meet the Professor and Speaker (Discussion with Q&A) Jessica Zucman-Rossi, Joong-Won Park, Young Nyun Park, Moon Seok Choi(Univ. Paris Descartes, France, Myongji Hospital, Hanyang Univ. , Yonsei Univ., Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:00~10:15 What is the Best Option for Advanced HCC?: Second-Line and Sequential Therapy  Bo Hyun Kim(National Cancer Center)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:15~10:30 Can We Predict Treatment Response in the Era of Immuno-Oncology? Do Young Kim (Yonsei Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:30~10:45 How to Expect and Manage the Adverse Events of Immunotherapy? Wonseok Kang (Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:45~11:00 How to Boost TKI Efficacy in Advanced HCC with Combination Therapies Ju Hyun Shim (Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:00~11:20 Meet the Professor and Speaker (Discussion with Q&A) Tim Meyer, Jong Young Choi, Lorenza Rimassa, Ho Yeong Lim(Univ. College London, UK, The Catholic Univ. of Korea, Humanitas Univ., Italy,  Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:40~11:55 What are the Current and Future Trends in Imaging Diagnosis of HCC? So Yeon Kim(Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:55~12:10 Imaging-Based Prediction of Prognosis for HCC Seung Baek Hong (Pusan National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 12:10~12:25 Surveillance and Post-Treatment Response Evaluation Eun Sun Jang (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 12:25~12:40 Optimal Medical Care to Improve Outcomes after HCC Treatment Sung Won Lee (The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 13:40~13:55 Evolving Role of TACE in the Intermediate-Stage HCC: Good or Poor Responders? Dongho Hyun(Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 13:55~14:10 Transarterial Radioembolization for HCC: Patient Selection and Assessment Hyo-Cheol Kim (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:10~14:25 Evolution of Radiotherapy for HCC: Balancing Tumor Control and Hepatic Function Preservation Sang Min Yoon(Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:25~14:40 Particle Beam Radiotherapy: Best Indications for HCC Tae Hyun Kim(National Cancer Center)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:40~14:55 Minimally Invasive Liver Resection for HCC and CCC Dong-Sik Kim(Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:55~15:10 Liver Transplantation in HCC and CCC: Expanding Indications Dong Jin Joo (Yonsei Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 15:10~15:25 Clinical Decision in Borderline Lesions for Local Ablation Therapy Dong Ho Lee (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 15:25~15:40 Role of Local Ablation Therapy as a Bridge for Curative Therapy Joon-Il Choi (The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:00~16:20 HCC with Intermediate Stage Jung Hee Kim (Hallym Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:20~16:40 HCC with Vascular Invasion Young-Sun Lee (Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:40~17:00 HCC with Metastasis Sangyoun Hwang(Dongnam Inst. of Radiological £¦ Medical Sciences)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦ 37Â÷ º½ Çмú´ëȸ(2ÀÏÂ÷) : 2024-04-06
´ÙÀ½±Û ÇѾç´ëÇб³º´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-04-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
363 ´ë±¸ ´ëÇÑÄ¡¸ÅÇÐȸ ´ë±¸°æºÏÁöȸ 2018 Ãß°è ½ÉÆ÷Áö¿ò : 2018-09-13 0 459 2018-08-08
362 ÀüºÏ Á¦6ȸ ÀüºÏ´ëÇб³º´¿ø Áö¿ªÀǾàÇ°¾ÈÀü¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-11 0 362 2018-08-08
361 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦17ȸ ¿¬¼ö°­Á : 2018-09-09 0 455 2018-08-08
360 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇаúÀÇ»çȸ 2018 Ãß°èÇмú´ëȸ : 2018-09-09 1 1,054 2018-08-08
359 ¼­¿ï 2018³âµµ ³úÆÄÁ¤µµ°ü¸®À§¿øȸ Á¤±â±³À° : 2018-09-09 0 667 2018-08-08
358 °æ³² Á¦1ȸ µ¿ºÎ°æ³²Çмú´ëȸ : 2018-09-08 0 851 2018-08-08
357 ¼­¿ï °æÈñ´ëÇб³º´¿ø ¹é¹ÝÁõ°ú »ö¼ÒÁúȯ : 2018-09-08 0 839 2018-08-08
356 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ Asthma School 2018 : 2018-09-08 0 374 2018-08-08
355 ¼­¿ï 2018³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-08 0 406 2018-08-08
354 ºÎ»ê 2018 ´ëÇѾȰúÀÇ»çȸ 5Â÷ ½ÉÆ÷Áö¿ò : 2018-09-08 0 721 2018-08-08
353 ºÎ»ê ´ëÇÑôÃß¿Ü°úÇÐȸ ºÎ¿ï°æ ´ë±¸ÇÕµ¿ ôÃßÁöȸ ¼¼¹Ì³ª : 2018-09-08 0 577 2018-08-08
352 ±¤ÁÖ ´ëÇÑôÃß¿Ü°úÇÐȸ 2018 ±¤ÁÖ±¹Á¦Ã´Ãß½ÉÆ÷Áö¿ò : 2018-09-08 0 324 2018-08-08
351 ÃæºÏ Á¦14Â÷ ´ëÀüÃæû¼Ò¾Æ½Å°æÁöȸ ½ÉÆ÷Áö¾ö : 2018-09-08 0 731 2018-08-08
350 ¼­¿ï 2018³â ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2018-09-07 0 729 2018-08-08
349 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 450 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷